Acetylation of asymmetric and symmetric dimethylarginine: An undercharacterized pathway of metabolism of endogenous methylarginines

Nephrology Dialysis Transplantation

Volumn 31, Issue 1, 2016, Pages 57-63

  Rodionov, Roman N ^a   Martens Lobenhoffer, Jens ^b   Brilloff, Silke ^a   Burdin, Dmitry V ^c   Jarzebska, Natalia ^a   Demyanov, Anton V ^d   Hohenstein, Bernd ^a   Weiss, Norbert ^a   Bode Böger, Stefanie M ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d Institute for Highly Pure Biopreparations   (Russian Federation)

Author keywords

Ac ADMA; Ac SDMA; acetylation; ADMA; nephrectomy; SDMA

Indexed keywords

6 N,N' DIMETHYLARGININE; N(G),N(G) DIMETHYLARGININE; ARGININE; N,N'-DIMETHYLARGININE; N,N-DIMETHYLARGININE;

ACETYLATION; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; KIDNEY PARENCHYMA; LIQUID CHROMATOGRAPHY; LIVER PARENCHYMA; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; OSMOTIC PUMP; PANCREAS; PRIORITY JOURNAL; SMALL INTESTINE; SPLEEN; TANDEM MASS SPECTROMETRY; TISSUE LEVEL; URINARY EXCRETION; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; C57BL MOUSE; KIDNEY; METABOLISM; PROTEIN PROCESSING;

ACETYLATION; ANIMALS; ARGININE; CHROMATOGRAPHY, LIQUID; KIDNEY; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; NEPHRECTOMY; ORGAN SPECIFICITY; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84960193708     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv390     Document Type: Article

References (31)

1. Boger RH, Cooke JP, Vallance P. ADMA: an emerging cardiovascular risk factor. Vasc Med 2005; 10 (Suppl 1): S1-S2
2. Cooke JP. Asymmetrical dimethylarginine: the Uber marker?. Circulation 2004; 109: 1813-1818
3. Anthony S, Leiper J, Vallance P. Endogenous production of nitric oxide synthase inhibitors. Vasc Med 2005; 10 (Suppl 1): S3-S9
4. Schwedhelm E, Boger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 2011; 7: 275-285
5. Bode-Boger SM, Scalera F, Kielstein JT, et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 2006; 17: 1128-1134
6. Speer T, Rohrer L, Blyszczuk P, et al. Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity 2013; 38: 754-768
7. Schepers E, Glorieux G, Dhondt A, et al. Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 2009; 24: 1429-1435
8. Veldink H, Faulhaber-Walter R, Park JK, et al. Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6/J mice. Nephrol Dial Transplant 2013; 28: 1434-1439
9. Leiper J, Nandi M, Torondel B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 2007; 13: 198-203
10. Hu X, Atzler D, Xu X, et al. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol 2011; 31: 1540-1546
11. Dayoub H, Achan V, Adimoolam S, et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 2003; 108: 3042-3047
12. Dayoub H, Rodionov RN, Lynch C, et al. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginineinduced endothelial dysfunction in the cerebral circulation. Stroke 2008; 39: 180-184
13. Rodionov RN, Dayoub H, Lynch CM, et al. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res 2010; 106: 551-558
14. Stuhlinger MC, Conci E, Haubner BJ, et al. Asymmetric dimethyl L-Arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc Res 2007; 75: 417-425
15. Jacobi J, Maas R, Cordasic N, et al. Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Am J Physiol Heart Circ Physiol 2008; 294: H1058-H1066
16. Hasegawa K, Wakino S, Tatematsu S, et al. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res 2007; 101: e2-e10
17. Ogawa T, Kimoto M, Sasaoka K. Dimethylarginine: pyruvate aminotransferase in rats. Purification, properties, and identity with alanine: glyoxylate aminotransferase 2. J Biol Chem 1990; 265: 20938-20945
18. Rodionov RN, Murry DJ, Vaulman SF, et al. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production. J Biol Chem 2010; 285: 5385-5391
19. Caplin B, Wang Z, Slaviero A, et al. Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure. Arterioscler Thromb Vasc Biol 2012; 32: 2892-2900
20. Ogawa T, Kimoto M, Watanabe H, et al. Metabolism of NG, NG-And NG, N0G-dimethylarginine in rats. Arch Biochem Biophys 1987; 252: 526-537
21. Sasaoka K, Ogawa T, Kimoto M. N-Acetyl conjugates of basic amino acids newly identified in rat urine. Arch Biochem Biophys 1982; 219: 454-458
22. Martens-Lobenhoffer J, Bode-Boger SM. Amino acid N-Acetylation: metabolic elimination of symmetric dimethylarginine as symmetric Nα-Acetyldimethylarginine, determined in human plasma and urine by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 975: 59-64
23. Martens-Lobenhoffer J, Rodionov RN, Bode-Boger SM. Determination of asymmetric Nα-Acetyldimethylarginine in humans: a phase II metabolite of asymmetric dimethylarginine. Anal Biochem 2014; 452: 25-30
24. Jacobi J, Sydow K, von Degenfeld G, et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation 2005; 111: 1431-1438
25. Martens-Lobenhoffer J, Bode-Boger SM. Quantification of L-Arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 904: 140-143
26. Carello KA, Whitesall SE, Lloyd MC, et al. Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats.AmJ Physiol Heart Circ Physiol 2006; 290: H209-H216
27. Bloch K, Rittenberg D. The metabolism of acetylamino acids. J Biol Chem 1947; 169: 467-476
28. Polevoda B, Sherman F. Nα-Terminal acetylation of eukaryotic proteins. J Biol Chem 2000; 275: 36479-36482
29. Wiame E, Tyteca D, Pierrot N, et al. Molecular identification of aspartate N-Acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 2010; 425: 127-136
30. Endo Y. In vivo deacetylation of N-Acetyl amino acids by kidney acylases in mice and rats. A possible role of acylase system in mammalian kidneys. Biochim Biophys Acta 1980; 628: 13-18
31. Liebich HM, Forst C. Urinary excretion of N-Acetylamino acids. J Chromatogr 1985; 338: 187-191